Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020
Start here
Turn the raw legal text into a practical explanation grounded in Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020.
(1) The price for a container for a ready‑prepared pharmaceutical benefit is the sum of: (a) the wholesale cost worked out under subsection (2); and (b) the mark‑up worked out under subsection (4). (2) The wholesale cost for a container will be based on the average of wholesale costs for a particular container, in a quantity of 100, as agreed by the Minister and the Pharmacy Guild of Australia for the supply of the container, by a wholesale drug distributor. (3) The wholesale cost must be agreed by 15 June in a year and takes effect on 1 August in that year. (4) For paragraph (1)(b), the mark‑up is 10% of the amount agreed under subsection (2). (5) For a mark‑up worked out under subsection (4), if the calculation of a percentage of the wholesale cost includes a fraction of a cent, the mark‑up is to be rounded up or down to the nearest cent, with an amount of 0.5 of a cent or more being rounded up to the next cent. (6) In this section:
container means:
(a) for a ready‑prepared pharmaceutical benefit that is injectable—a vial with a capacity of 150 ml; or
(b) for any other ready‑prepared pharmaceutical benefit—a vial with a capacity of 25 ml.